Discounting in Economic Evaluations

PharmacoEconomics
Arthur E AttemaKarl Claxton

Abstract

Appropriate discounting rules in economic evaluations have received considerable attention in the literature and in national guidelines for economic evaluations. Rightfully so, as discounting can be quite influential on the outcomes of economic evaluations. The most prominent controversies regarding discounting involve the basis for and height of the discount rate, whether costs and effects should be discounted at the same rate, and whether discount rates should decline or stay constant over time. Moreover, the choice for discount rules depends on the decision context one adopts as the most relevant. In this article, we review these issues and debates, and describe and discuss the current discounting recommendations of the countries publishing their national guidelines. We finish the article by proposing a research agenda.

References

Mar 31, 1977·The New England Journal of Medicine·M C Weinstein, W B Stason
Apr 1, 1992·Health Economics·J Cairns
Jul 1, 1994·Health Economics·J A Cairns
Dec 9, 1998·Health Economics·B A van Hout
Apr 5, 2001·Social Science & Medicine·M van der Pol, J Cairns
Jul 12, 2001·International Journal of Technology Assessment in Health Care·D H Smith, H Gravelle
Oct 9, 2002·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Gretchen B Chapman
Feb 4, 2003·Health Economics·Linda D MacKeiganBernie J O'Brien
Dec 21, 2004·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Dorte Gyrd-Hansen
May 12, 2005·Social Science & Medicine·Bjarne Robberstad
Aug 20, 2005·BMJ : British Medical Journal·Werner B F BrouwerFrans F H Rutten
Dec 21, 2005·Health Economics·Karl ClaxtonJohn Brazier
Sep 29, 2006·Health Economics·Hugh GravelleFrans Rutten
Dec 13, 2007·Health Economics·Arthur E Attema, Werner B F Brouwer
Jan 9, 2008·Journal of Health Economics·Werner B F BrouwerFrans F H Rutten
Dec 9, 2008·Journal of Health Economics·Arthur E Attema, Werner B F Brouwer
Feb 1, 2005·Expert Review of Pharmacoeconomics & Outcomes Research·Rogier M KlockMaarten J Postma
Jul 28, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Arthur E Attema, Werner B F Brouwer
Dec 15, 2010·Health Economics·Karl ClaxtonAnthony J Culyer
Dec 21, 2010·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Mareike Schad, Jürgen John
Mar 26, 2011·Health Economics·Mike Paulden, Karl Claxton
Sep 13, 2011·Health Care Analysis : HCA : Journal of Health Philosophy and Policy·Gustav Tinghög
Jan 27, 2012·Journal of Health Economics·Arthur E Attema, Werner B F Brouwer
May 16, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Tjalke A WestraMaarten J Postma
Dec 12, 2012·Health Economics·Arthur E Attema, Matthijs M Versteegh
Aug 17, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·James F O'Mahony, Mike Paulden
Jan 1, 2018·Journal of Risk and Uncertainty·Arthur E AttemaValérie Seror

❮ Previous
Next ❯

Citations

Apr 24, 2019·Tropical Medicine & International Health : TM & IH·Hugo C TurnerMaría-Gloria Basáñez
Oct 19, 2019·Health Policy and Planning·Markus HaackerRifat Atun
Dec 5, 2019·Applied Health Economics and Health Policy·Sebastian HindeGerry Richardson
Dec 31, 2019·Paediatric and Perinatal Epidemiology·Emily J CallanderDavid Ellwood
Feb 1, 2020·European Heart Journal. Acute Cardiovascular Care·Salla Jäämaa-HolmbergJyri Lommi
Jun 2, 2020·Australian Health Review : a Publication of the Australian Hospital Association·Nancy Devlin, Paul Scuffham
Jul 10, 2020·Risk Analysis : an Official Publication of the Society for Risk Analysis·Kimberly M Thompson, Dominika A Kalkowska
Aug 14, 2020·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Klas KellerborgPieter van Baal
Feb 13, 2019·PharmacoEconomics·Matthew FranklinTracey Young
Aug 4, 2019·Current Diabetes Reports·Cátia BandeirasRobert A Gabbay
Dec 24, 2019·Cost Effectiveness and Resource Allocation : C/E·Jürgen JohnMareike Schad
Jan 12, 2019·Obstetrics and Gynecology·Abriana TasilloBenjamin P Linas
Jun 30, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Simone N KooleValesca P Retèl
Apr 12, 2019·Health and Quality of Life Outcomes·Christina-Jane Crossman-BarnesGarry Barton
Feb 2, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Johannes PöhlmannBarnaby Hunt
Sep 21, 2019·Applied Health Economics and Health Policy·Marta Giulia Viola, Alexander Diamantopoulos
Apr 29, 2020·PharmacoEconomics·Michelle Q T KwokJames F O'Mahony
Jun 5, 2020·Expert Review of Pharmacoeconomics & Outcomes Research·Mir Mahmood AsrarDipika Bansal
Jul 16, 2020·European Journal of Preventive Cardiology·Feby SaviraElla Zomer
Oct 6, 2020·Therapeutic Advances in Gastroenterology·Stéphanie BarréFrédéric De Bels
Apr 8, 2020·ClinicoEconomics and Outcomes Research : CEOR·Stephanie F Armstrong, Julian F Guest
Jul 2, 2020·ClinicoEconomics and Outcomes Research : CEOR·C AzzariL J Wolfson
Apr 25, 2020·PharmacoEconomics·Paul Catchpole, Victoria Barrett
Sep 7, 2018·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Werner BrouwerMatthijs Versteegh
Mar 27, 2020·Clinical Oral Implants Research·Carine MatthysHugo De Bruyn
Nov 3, 2020·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Hye-Young KwonJinhyun Kim
Sep 22, 2020·Expert Review of Pharmacoeconomics & Outcomes Research·Anders GustavssonRobin Thompson
Nov 27, 2020·Frontiers in Public Health·Laurent MusangoJoses Muthuri Kirigia
Sep 12, 2020·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hirosato AokiDaisuke Kitagawa
Jan 21, 2021·International Journal of Paediatric Dentistry·Helen Jessica RogersChristopher Robert Vernazza
Jan 23, 2021·ANZ Journal of Surgery·Ravi VissapragadaDavid I Watson
Feb 10, 2021·Journal of Environmental Management·Isabel Seifert-DähnnDon Pierson

❮ Previous
Next ❯

Software Mentioned

CatSalut

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.